JSJeremy A. Schofield

Jeremy A. Schofield

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jeremy A. Schofield has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Transcriptional bursting, gene activation, and roles of SAGA and Mediator Tail measured using nucleotide recoding single cell RNA-seq

    by Jeremy A Schofield, Steven Hahn

    A time resolved nascent single-cell RNA-seq approach was developed to dissect gene-specific transcriptional bursting and the roles of SAGA and Mediator Tail (the activator-binding module). Most yeast genes show near-constitutive behavior while only a subset of genes show high mRNA variance suggestive of transcription bursting. Bursting behavior is highest in the coactivator redundant (CR) gene class (dependent on both SAGA and TFIID) and is strongest in TATA-containing CR genes. Applying this approach to analyze gene activation, we found that basal histone gene transcription is in a low level, low-noise constitutive mode while the activated state unexpectedly shows an increase in both the fraction of active promoters and a switch to a noisy and bursty transcription mode. Rapid depletion of either SAGA or Mediator Tail suggests that both factors play an important role in stimulating the fraction of active promoters at CR genes, with a variable gene-specific role in transcriptional bursting.


  • Open Access

    Improving the study of RNA dynamics through advances in RNA-seq with metabolic labeling and nucleotide-recoding chemistry

    by Joshua T. Zimmer, Isaac W. Vock, Jeremy A. Schofield, Lea Kiefer, Michelle H. Moon, Matthew D. Simon

    RNA metabolic labeling using 4-thiouridine (s 4 U) captures the dynamics of RNA synthesis and decay. The power of this approach is dependent on appropriate quantification of labeled and unlabeled sequencing reads, which can be compromised by the apparent loss of s 4 U-labeled reads in a process we refer to as dropout. Here we show that s 4 U-containing transcripts can be selectively lost when RNA samples are handled under sub-optimal conditions, but that this loss can be minimized using an optimized protocol. We demonstrate a second cause of dropout in nucleotide recoding and RNA sequencing (NR-seq) experiments that is computational and downstream of library preparation. NR-seq experiments involve chemically converting s 4 U from a uridine analog to a cytidine analog and using the apparent T-to-C mutations to identify the populations of newly synthesized RNA. We show that high levels of T-to-C mutations can prevent read alignment with some computational pipelines, but that this bias can be overcome using improved alignment pipelines. Importantly, kinetic parameter estimates are affected by dropout independent of the NR chemistry employed, and all chemistries are practically indistinguishable in bulk, short-read RNA-seq experiments. Dropout is an avoidable problem that can be identified by including unlabeled controls, and mitigated through improved sample handing and read alignment that together improve the robustness and reproducibility of NR-seq experiments.


  • Open Access

    Broad compatibility between yeast UAS elements and core promoters and identification of promoter elements that determine cofactor specificity

    by Jeremy A. Schofield, Steven Hahn

    Three general classes of yeast protein-coding genes are distinguished by their dependence on the transcription cofactors TFIID, SAGA and Mediator (MED) Tail, but little is known about whether this dependence is determined by the core promoter, Upstream activation sites (UASs), or other gene features. It is also unclear whether UASs can broadly activate transcription from the different promoter classes or whether efficient transcription requires matching UASs and promoters of similar gene class. Here we measure transcription and cofactor specificity for tens of thousands of UAS-core promoter combinations. We find that <5% of UASs display strong core promoter specificity while most UASs can broadly activate promoters regardless of regulatory class. However, we find that matching UASs and promoters from the same gene class is generally important for optimal expression. From examining the cofactor dependence of this large UAS-promoter set, we find that sensitivity to rapid depletion of MED Tail or SAGA is dependent on the identity of both UAS and promoter while dependence on TFIID localizes to only the core promoter. Our results explain why transcription factor-mediated MED recruitment to the UAS does not always result in Tail-dependent transcription and highlight the role of TATA and TATA-like promoter sequences in MED Tail function.

  • Discovery of cellular substrates of human RNA-decapping enzyme DCP2 using a stapled bicyclic peptide inhibitor

    by Yang Luo, Jeremy A. Schofield, Zhenkun Na, Tanja Hann, Matthew D. Simon, Sarah A. Slavoff


  • Global Profiling of Cellular Substrates of Human Dcp2

    by Yang Luo, Jeremy A. Schofield, Matthew D. Simon, Sarah A. Slavoff

    Decapping is the first committed step in 5'-to-3' RNA decay, and in the cytoplasm of human cells, multiple decapping enzymes regulate the stabilities of distinct subsets of cellular transcripts. However, the complete set of RNAs regulated by any individual decapping enzyme remain incompletely mapped, and no consensus sequence or property is currently known to unambiguously predict decapping enzyme substrates. Dcp2 was the first-identified and best-studied eukaryotic decapping enzyme, but it has been shown to regulate the stability of <400 transcripts in mammalian cells to date. Here, we globally profile changes in stability of the human transcriptome in Dcp2 knockout cells via TimeLapse-seq. We find that P-body enrichment is the strongest correlate of Dcp2-dependent decay, and that modification with m6A exhibits an additive effect with P-body enrichment for Dcp2 targeting. These results are consistent with a model in which P-bodies represent sites where translationally repressed transcripts are sorted for decay by soluble cytoplasmic decay complexes through additional molecular marks.


  • p53 Activates the Long Noncoding RNA Pvt1b to Inhibit Myc and Suppress Tumorigenesis

    by Christiane E. Olivero, Elena Martínez-Terroba, Joshua Zimmer, Clara Liao, Ephrath Tesfaye, Nima Hooshdaran, Jeremy A. Schofield, Jordan Bendor, Dorthy Fang, Matthew D. Simon, et al.


  • Gaining insight into transcriptome‐wide RNA population dynamics through the chemistry of 4‐thiouridine

    by Erin E. Duffy, Jeremy A. Schofield, Matthew D. Simon

    Cellular RNA levels are the result of a juggling act between RNA transcription, processing, and degradation. By tuning one or more of these parameters, cells can rapidly alter the available pool of transcripts in response to stimuli. While RNA sequencing (RNA‐seq) is a vital method to quantify RNA levels genome‐wide, it is unable to capture the dynamics of different RNA populations at steady‐state or distinguish between different mechanisms that induce changes to the steady‐state (i.e., altered rate of transcription vs. degradation). The dynamics of different RNA populations can be studied by targeted incorporation of noncanonical nucleosides. 4‐Thiouridine (s4U) is a commonly used and versatile RNA metabolic label that allows the study of many properties of RNA metabolism from synthesis to degradation. Numerous experimental strategies have been developed that leverage the power of s4U to label newly transcribed RNA in whole cells, followed by enrichment with activated disulfides or chemistry to induce C mutations at sites of s4U during sequencing. This review presents existing methods to study RNA population dynamics genome‐wide using s4U metabolic labeling, as well as a discussion of considerations and challenges when designing s4U metabolic labeling experiments.This article is categorized under: RNA Methods > RNA Analyses in Cells RNA Turnover and Surveillance > Regulation of RNA Stability


  • Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-Thioguanosine

    by Lea Kiefer, Jeremy A. Schofield, Matthew D. Simon

    RNA-sequencing (RNA-seq) measures RNA abun-dance in a biological sample but does not provide temporal information about the sequenced RNAs. Metabolic labeling can be used to distinguish newly made RNAs from pre-existing RNAs. Mutations induced from chemical recoding of the hydrogen bonding pattern of the metabolic label can reveal which RNAs are new in the context of a sequencing experiment. These nucleotide recoding strategies have been developed for a single uridine analogue, 4-thiouridine (s4U), limiting the scope of these ex-periments. Here we report the first use of nucleo-side recoding with a guanosine analogue, 6-thioguanosine (s6G). Using TimeLapse sequencing (TimeLapse-seq), s6G can be recoded under RNA-friendly oxidative nucleophilic-aromatic substitu-tion conditions to produce adenine analogues (substituted 2-aminoadenosines). We demonstrate the first use of s6G recoding experiments to reveal tran-scriptome-wide RNA population dynamics.


  • TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding

    by Jeremy A Schofield, Erin E Duffy, Lea Kiefer, Meaghan C Sullivan, Matthew D Simon

    TimeLapse-seq chemically recodes labeled s4U nucleosides to a cytidine derivative and monitors transcriptional dynamics. RNA sequencing (RNA-seq) offers a snapshot of cellular RNA populations, but not temporal information about the sequenced RNA. Here we report TimeLapse-seq, which uses oxidative-nucleophilic-aromatic substitution to convert 4-thiouridine into cytidine analogs, yielding apparent U-to-C mutations that mark new transcripts upon sequencing. TimeLapse-seq is a single-molecule approach that is adaptable to many applications and reveals RNA dynamics and induced differential expression concealed in traditional RNA-seq.


  • Metal–Halogen Secondary Bonding in a 2,5‐Dichlorohydroquinonate Cobalt(II) Complex: Insight into Substrate Coordination in the Chlorohydroquinone Dioxygenase PcpA

    by Jeremy A. Schofield, William W. Brennessel, Eugenijus Urnezius, Dalia Rokhsana, Monica D. Boshart, Douglas H. Juers, Patrick L. Holland, Timothy E. Machonkin

    Despite the unprecedented selectivity of the hydroquinone ring‐cleaving dioxygenase PcpA for ortho‐chlorohydroquinones, there are no examples of an ortho‐chlorohydroquinone bound to a transition‐metal complex. Herein, the synthesis and characterization of (TpPh2Co)2(μ‐2,5‐dichlorohydroquinonate), for which TpPh2 is tris(3,5‐diphenylpyrazolyl)borate, were explored. The dianionic 2,5‐dichlorohydroquinonate bridges two (TpPh2Co) moieties and coordinates each cobalt(II) center through the oxygen and chlorine atoms of the chlorohydroquinone. The Co–Cl distance of 2.778 Å shows the characteristics of a metal–halogen secondary bond, as we previously showed in ortho‐halophenolate complexes. This compound represents the first example of metal–halogen secondary bonding with a halohydroquinone and, thus, provides a potential structural model for selective substrate binding to the metal center in PcpA.